Non-atherosclerotic coronary causes of myocardial infarction in women

Abhishek Chaturvedi1, Naga Vaishnavi Gadela2, Kriti Kalra3

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States.

PubMed

Insights

Myocardial infarction (MI) in women often stems from non-atherosclerotic causes, unlike men. Recognizing these diverse mechanisms is crucial for accurate diagnosis and treatment, as women are disproportionately affected.

Area of Science:

  • Cardiology
  • Women's Health
  • Pathophysiology

Background:

  • Ischemic heart disease is a leading cause of death in women globally.
  • While obstructive coronary atherosclerosis is common, non-atherosclerotic causes of myocardial infarction (MI) are increasingly recognized.
  • Women experience MI without atherosclerosis more frequently than men, yet remain underdiagnosed and undertreated.

Purpose of the Study:

  • To review non-atherosclerotic coronary causes of MI.
  • To focus on evidence specific to women.
  • To provide a foundation for future research.

Main Methods:

  • Literature review of existing studies.
  • Focus on non-atherosclerotic mechanisms of MI.
  • Emphasis on data pertaining to women.

Main Results:

  • Non-atherosclerotic MI mechanisms include spontaneous coronary artery dissection, vasospasm, microvascular dysfunction, and others.
  • Women are 2-5 times more likely to have MI without atherosclerosis compared to men.
  • Advancements in imaging and physiological testing aid in diagnosis and treatment.

Conclusions:

  • Non-atherosclerotic MI is a significant concern in women.
  • Improved understanding and diagnostic tools are essential for better outcomes.
  • Further research is needed to address diagnosis and treatment disparities.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
511
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
448
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
2.2K